Medical Marijuana Inc (OTCMKTS: MJNA) Analyst Review


The company, incorporated in May 2005, is a development stage company operating in the fields of cannabis and industrial hemp in America. Through subsidiaries and investment holdings, the company is focused on the development, sales and distribution of hemp oil containing naturally occurring cannabinoids, including cannabidiol and other products rich in the product. The products are formulated for the use of the pharmaceutical, nutraceuticals and cosmecuiticals industries including dietary supplements containing prescription based hemp oil in countries which have legalised hemp oil for various treatments. The services include development of cannabinoid-based health and wellness products and the development of compounds for medical use. The company operates through a number of subsidiaries such as Wellness Managed Services LLC and others.

HempMedsPX, LLC is the principal distributor through subsidiaries and associates, including Puerto Rico and Mexico for the portfolio of legal hemp products and the flagship product is Real Scientific Hemp Oil, which is a full spectrum hemp oil containing natural ingredients. The supplements contain between 10% and 30% and are available in three varieties. Wellness Managed Services, LLC provides management support and services to cooperatives and facilities as well as medical clinics. And owns interests in firms that provide consulting and security services in the legal cannabis business. Red Dice Holdings LLC owns the Dixie Botanica brand while CanChew Biotechnologies focuses on the treatment of pain and medical disorders through the use of chewing gum based medical products. Finally Hempwire LLC is a joint-venture for the marketing and distribution of rich hemp oil functional food sales and nutritional supplements.

Legal cannabis industry prospects

Legal cannabis is one of the fastest growing industries in the United States, and well over 20,000 studies in detail the benefits of medical cannabis for people who face a number of diseases ranging from Alzheimer’s to chronic pain to diabetes. It is fast becoming a mainstream product because of the huge amounts of scientific research, favourable public opinion and a more benign legal system. More than 1.2 million people are already using medical marijuana for a number of medical problems. The estimated size of the legal industry in the US is $ 7.1 billion in 2016, which is an increase of more than 25% over the previous year. The increase is because of states like Colorado, Washington and Oregon expected to approve both the medical and recreational use of the substance. The number of Americans who support the legalisation of marijuana for medical purposes is 89% compared to 74% in 2011. The public is becoming increasingly more aware and trusting. 25 states, as well as Washington, DC, and Puerto Rico have already legalised the use of medical marijuana and some of them are expected to authorise recreational use as well. In 2015, alone, $ 996 million of recreational and medical sales in Colorado were witnessed accompanied by $ 661 million in recreational sales in Washington. Tax revenue from the sale of recreational marijuana is already being used for the purposes of education, feeding the homeless and infrastructure improvement. The size of the 2015 hemp market was $ 573 million without taking into account sales data from big box retailers and 56% of physicians support the nationwide legalised sales. 183 million people use marijuana in 2014 according to the UN, which makes it one of the most commonly used drugs in the world.

The bottom line

It should be remembered that the company does not actually manufacture and distribute medical marijuana, but focuses instead on the development and sale of hemp oil and hemp oil derived products. Its operations are carried out through eight fully owned or partially owned subsidiaries. The company has a current market capitalisation in the region of around $ 460 million and, because the earnings have been negative, it is not possible to calculate a price/ earnings ratio. There are several other risks to be taken into account as well. The negative earnings have resulted in a continuous weakening of the cash position and the company will need to raise more cash through the use of debt or the dilation of equity through the raising of additional equity. Debt has already become an issue because of the existing long-term liabilities of $ 12 million and current liabilities of $ 5 million. Solvency will continue to be a major worry. However, what should console potential investors is the possession of marijuana as a growth industry.


Traders News Source Mission Statement
We strive to highlight the future potential as well as the inherent risk in each small cap company we cover while remaining neutral as a leading third-party equity research firm. Please read our privacy policy and full disclaimer below.


***Receive updates and real time small cap stock profiles from Traders News Source by sending a text from your mobile phone to the number “25-827” with the word “Traders” as the message.

Opt out anytime by replying “Stop”

Our group is up over 170% since December 2016 with four profiles. Stay tuned our next small cap profile will be issued via text and email soon.



Traders News Source is a wholly owned subsidiary of Traders News Source LLC, herein referred to as TNS LLC.
Traders News Source has not been compensated for this report by anyone and the opinions if any are that of the author Stuart Quint, CFA. Author’s Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I, wrote this article myself, and it expresses my own opinions. I have no business relationship with any company whose stock is mentioned in the article.
This web site, published by TNS LLC, and is an investment newsletter that is built on the premise of assisting individual investors in learning about investing. Our goal as publishers of financial information is to provide research and analysis of investments to our subscribers. TNS LLC does not give buy or sell recommendations. We do purchase distribution rights from analyst, financial writers and bloggers for a fee that may be licensed to issue price targets and recommendations. Furthermore, we encourage you to speak to a licensed professional prior to making an investment in any type of publicly traded security.
We do sell advertising to other companies including brokerage firms, web sites, publicly traded issuers, investor relations firms, and investment publications, among others. TNS LLC makes no warranty as to the policies of these organizations, and in no way endorses their offers, services, or the content of their advertisements.
When an advertiser is a publicly traded company or a third party acting on behalf of a public company, we fully disclose all compensation in the email advertisement. Such disclosure is included in a disclosure statement in each of the advertisements sent via email.
17B Disclosure
Our reports/releases are a commercial advertisement and are for general information purposes ONLY. We are engaged in the business of marketing and advertising companies for monetary compensation. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our services, joining our site or our email/blog list as well as any social networking platforms we may use.
PLEASE NOTE WELL: TNS LLC and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever.
Release of Liability: Through use of this website viewing or using you agree to hold TNS LLC, its operator’s owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. TNS LLC encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and TNS LLC makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. None of the materials or advertisements herein constitute offers or solicitations to purchase or sell securities of the companies profiled herein and any decision to invest in any such company or other financial decisions should not be made based upon the information provide herein. Instead TNS LLC strongly urges you conduct a complete and independent investigation of the respective companies and consideration of all pertinent risks. Readers are advised to review SEC periodic reports: Forms 10-Q, 10K, Form 8-K, insider reports, Forms 3, 4, 5 Schedule 13D.
TNS LLC is compliant with the Can Spam Act of 2003. TNS LLC does not offer such advice or analysis, and TNS LLC further urges you to consult your own independent tax, business, financial and investment advisors. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor’s investment may be lost or impaired due to the speculative nature of the companies profiled.
The Private Securities Litigation Reform Act of 1995 provides investors a ‘safe harbor’ in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be “forward looking statements”. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as “projects”, “foresee”, “expects”, “will”, “anticipates”, “estimates”, “believes”, “understands”, or that by statements indicating certain actions & quote; “may”, “could”, or “might” occur.
Understand there is no guarantee past performance will be indicative of future results. In preparing this publication, TNS LLC has relied upon information supplied by its customers, publicly available information and press releases which it believes to be reliable; however, such reliability cannot be guaranteed. Investors should not rely on the information contained in this website. Rather, investors should use the information contained in this website as a starting point for doing additional independent research on the featured companies. The advertisements in this website are believed to be reliable, however, TNS LLC and its owners, affiliates, subsidiaries, officers, directors, representatives and agents disclaim any liability as to the completeness or accuracy of the information contained in any advertisement and for any omissions of materials facts from such advertisement. TNS LLC is not responsible for any claims made by the companies advertised herein, nor is TNS LLC responsible for any other promotional firm, its program or its structure.